Skip to content


Investor Relations

We launched Atara Biotherapeutics in August 2012 to help patients combat cancer, kidney disease and other illnesses. Our research is based on groundbreaking discoveries regarding the ability of activin, myostatin and other growth factors to change the course of disease progression. Our goal is to help patients such as Atara Ciechanover, our company’s namesake, who suffered from cancer before passing away in 2012. We aim to empower patients to fight their illnesses with better treatment options.

- 0.25 (-1.44%)
Day High: 17.60
Day Low:  16.60
Volume:    363,589
4:00 PM ET on Apr 28, 2017

Delayed at least 20 minutes.